References
- Ahmed, O.A., et al., 2014. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches. Expert Opinion on Drug Delivery, 11 (7), 1005–1013.
- Alsarra, I.A., et al., 2005. Proniosomes as a drug carrier for transdermal delivery of ketorolac. European Journal of Pharmaceutics and Biopharmaceutics, 59 (3), 485–490.
- Ammar, H., et al., 2011. Proniosomes as a carrier system for transdermal delivery of tenoxicam. International Journal of Pharmaceutics, 405 (1-2), 142–152.
- Attwood, D., and Florence, A., 1983. Surfactant system. London, NY: Chapman and Hall.
- Baillie, A., et al., 1985. The preparation and properties of niosomes-non ionic surfactant vesicles. The Journal of Pharmacy and Pharmacology, 37 (12), 863–868.
- Bhulli, N., and Sharma, A., 2012. Preparation of novel vesicular carrier ethosomes with glimepiride and their invistigation of permeability. International Journal of Therapeutic Applications, 10, 1–10.
- Dawaba, H.M., et al., 2016. Investigation of proniosomes gel as a promising carrier for transdermal delivery of Glimepiride. Universal Journal of Pharmaceutical Research, 1 (2), 1–10.
- El Zaafarany, G.M., et al., 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. International Journal of Pharmaceutics, 397 (1-2), 164–172.
- Elsayed, M.M., et al., 2006. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. International Journal of Pharmaceutics, 322 (1-2), 60–66.
- Guinedi, A.S., et al., 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International Journal of Pharmaceutics, 306 (1-2), 71–82.
- Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by a noisome system. International Journal of Pharmaceutics, 244 (1-2), 73–80.
- Hillgren, A., Lindgren, J., and Aldén, M., 2002. Protection mechanism of Tween 80 during freeze-thawing of a model protein. International Journal of Pharmaceutics, 237 (1-2), 57–69.
- Honeywell-Nguyen, P.L., and Bouwstra, J.A., 2005. Vesicles as a tool for transdermal and dermal delivery. Drug Discovery Today. Technologies, 2 (1), 67–74.
- Junyaprasert, V.B., et al., 2012. Physicochemical properties and skin permeation of span 60/Tween 60 niosomes of ellagic acid. International Journal of Pharmaceutics, 423 (2), 303–311.
- Kakkar, S., and Kaur, I.P., 2011. Spanlastics—A novel nanovesicular carrier system for ocular delivery. International Journal of Pharmaceutics, 413 (1-2), 202–210.
- Kalluri, H., and Banga, A.K., 2011. Transdermal delivery of proteins. AAPS Pharmscitech, 12 (1), 431–441.
- Kaur, I.P., et al., 2012. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics, 28 (5), 484–496.
- Keleb, E., et al., 2010. Transdermal drug delivery system-design and evaluation. International Journal of Advances in Pharmaceutical Sciences, 1 (3), 201–211.
- Manosroi, A., et al., 2009. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles: Biological recognition and interactions of liposomes. Journal of Liposome Research, 19 (2), 91–98.
- Marianecci, C., et al., 2014. Niosomes from 80s to present: the state of the art. Advances in Colloid and Interface Science, 205, 187–206.
- Mellitus, D., 2005. Diagnosis and classification of diabetes mellitus. Diabetes Care, 28, S37.
- Mokhtar, M., et al., 2008. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International Journal of Pharmaceutics, 361 (1-2), 104–111.
- Murdan, S., Gregoriadis, G., and Florence, A.T., 1999. Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? European Journal of Pharmaceutical Sciences : official Journal of the European Federation for Pharmaceutical Sciences, 8 (3), 177–185.
- Razzaq, F.A., et al., 2021. Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation. Cells, 10, 2404.
- Sudaxshiina, M., et al., 1999. Water in sorbitan monostearate organogels (water in oil gels). Journal of Pharmaceutical Sciences, 88| (6), 615–619.
- Tarek, A., Ahmed ., et al., 2016. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation. International Journal of Pharmaceutics, 500 (1-2), 245–254.
- Tayel, S.A., et al., 2015. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. International Journal of Pharmaceutics, 483 (1-2), 77–88.
- Thomas, P.J., et al., 2001. Self-assembling bilayers of palladiumthiolates in organic media. Journal of Chemical Sciences, 113 (5-6), 611–619.
- van den Bergh, B.A., et al., 2001. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. International Journal of Pharmaceutics, 217 (1-2), 13–24.
- Vora, B., Khopade, A.J., and Jain, N., 1998. Proniosomes based transdermal delivery of levonorgestrel for effective contraception. Journal of Controlled Release, 54 (2), 149–165.
- Wacker, M., 2013. Nanocarriers for intravenous injection – the long hard road to the market. International Journal of Pharmaceutics, 457 (1), 50–62.
- Wissing, S.A., Kayser, O., and Müller, R.H., 2004. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews, 56 (9), 1257–1272.